The ISR2 protein is overexpressed in many cancer types and in vivo has been shown to enhance metastasis (54–56), BCAR3 is associated cellular migration and resistance to therapeutic anti-estrogens in breast cancer cells (57, 58). This evidence concerns the gene BCAR3 and breast carcinoma.